Max-Bio Biosciences Private Limited has acquired an 11.89% stake in Raconteur Global Resources through a preferential allotment of shares. The transaction involved the acquisition of 2,142,857 equity shares carrying voting rights.

The acquisition was completed on September 8, 2026. Max-Bio Biosciences is not part of the promoter or promoter group of Raconteur Global Resources. The deal increases Max-Bio’s total holding in the company to 11.89% of the total diluted share capital.

Transaction Details

The preferential allotment resulted in a change in the equity share capital of Raconteur Global Resources. Before the acquisition, the company’s equity share capital stood at 13,27,78,430 shares. Following the issuance of new shares to Max-Bio Biosciences, the total equity share capital increased to 18,02,78,420 shares.

Regulatory Disclosure

Max-Bio Biosciences filed the disclosure under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that there were no warrants, convertible securities, or other instruments entitling the acquirer to receive additional shares with voting rights as part of this transaction.

The target company, Raconteur Global Resources, is listed on the Bombay Stock Exchange (BSE). The disclosure was signed by Surinder Kalra, Director of Max-Bio Biosciences, on September 21, 2026.

Raconteur Global Resources Limited published the final scrutinizer’s report for its 8th Annual General Meeting held on September 18, 2026. All eight resolutions proposed by the board were passed with requisite majority, receiving 100% support from votes cast.

The meeting concluded at 1:39 pm after shareholders voted via video conferencing. Scrutinizer M/s Devender Singh & Associates confirmed that all resolutions received unanimous support from those who cast votes. Remote e-voting ran from September 15 to September 17, 2026, with results unblocked in the presence of two independent witnesses.

Voting Participation

The record date for the meeting was September 11, 2026. The company had 486 shareholders on record. Only 11 public shareholders attended the meeting through video conferencing, while no promoters were present physically or virtually. No physical meeting or proxy arrangements were made.

Note: Vote counts varied slightly across resolutions due to abstentions or non-voting on specific items by some shareholders.

Resolutions Passed

Shareholders approved ordinary and special resolutions covering financial statements, board appointments, and capital raises. Key outcomes included:

• Adoption of audited standalone and consolidated financial statements for FY26 ended March 31, 2026.
• Appointment of Ms. Hina as a director liable to retire by rotation.
• Appointment of M/s A S Bhutani & Associates as statutory auditors to fill a casual vacancy and for a five-year term until the 13th AGM.
• Reappointment of Mr. Sourabh Parnami and Mr. Arvinder Singh Kohli as independent directors.
• Authorization to issue up to 23,200,000 warrants convertible into equity shares at ₹12.50 per share to non-promoters.
• Authorization to allot 800,000 equity shares at ₹12.50 per share to Atharva Professional Consultants LLP.

Auditor and Director Details

M/s A S Bhutani & Associates (FRN: 029646N) was appointed effective August 20, 2026. The firm has audit experience across manufacturing, real estate, infrastructure, trading, and services sectors.

Mr. Sourabh Parnami’s appointment as independent director was regularized w.e.f. March 11, 2026. Mr. Arvinder Singh Kohli’s appointment was regularized w.e.f. March 18, 2026. Both serve five-year terms.

Attendance

Directors attending via video conferencing included Mr. Surinder Kalra (Whole Time Director), Ms. Hina (Whole Time Director, CFO), Mr. Yogesh Singh Rana (Whole Time Director), Ms. Gowhar Parveen Mallick (Non-Executive Director), and independent directors Mr. Parnami and Mr. Kohli. Secretarial auditor Mr. Shailendra Kumar Roy and scrutinizer Mr. Devender Singh were also present.